期刊文献+

Qualitative and Quantitative Analysis of Alkaloids in Cortex Phellodendri by HPLC-ESI-MS/MS and HPLC-DAD 被引量:19

Qualitative and Quantitative Analysis of Alkaloids in Cortex Phellodendri by HPLC-ESI-MS/MS and HPLC-DAD
下载PDF
导出
摘要 A combined method of high performance liquid chromatograph-elecrtrospray-ionization mass spectrometer(HPLC-ESI-MS/MS) coupled with a photodiode array detector(HPLC-DAD) and principal component analysis(PCA) was applied to the qualitative and quantitative analyses of alkaloids in Cortex Phellodendri(CP) samples, and to the differentiation of two species of CP, Cortex Phellodendri Chinensis(CPC) and Cortex Phellodendri Amurensis(CPA). Twenty-two peaks appeared in the HPLC-MS base peak chromatogram of CP detected by the HPLC-ESI-MS/MS analysis, and the alkaloids were identified according to the MSn data, the known MS fragmentation rules and the literature data. Five alkaloids including berberine, palmatine, jatrorrhizine, phellodendrine and magnoflorine were simultaneously determinated by the HPLC-DAD. Berberine was the primary component in all CP samples, and the contents of berberine and palmatine were exploited to be two critical parameters for effective discrimination between the two species of CP. The average content of berberine in CPC(58.75 mg/g) was higher than that in CPA(9.16 mg/g), while the content of palmatine was less, only 0.25 mg/g in CPC and 4.19 mg/g in CPA. With the use of PCA, samples datasets were separated successfully into two different clusters corresponding to the two species, and berberine, pahnatine, phellodendrine and magnoflorine contribute most to the above mentioned calssifying . The proposed method oroved to be a useful tool in the aualitv control of Chinese herbal medicines. A combined method of high performance liquid chromatograph-elecrtrospray-ionization mass spectrometer(HPLC-ESI-MS/MS) coupled with a photodiode array detector(HPLC-DAD) and principal component analysis(PCA) was applied to the qualitative and quantitative analyses of alkaloids in Cortex Phellodendri(CP) samples, and to the differentiation of two species of CP, Cortex Phellodendri Chinensis(CPC) and Cortex Phellodendri Amurensis(CPA). Twenty-two peaks appeared in the HPLC-MS base peak chromatogram of CP detected by the HPLC-ESI-MS/MS analysis, and the alkaloids were identified according to the MSn data, the known MS fragmentation rules and the literature data. Five alkaloids including berberine, palmatine, jatrorrhizine, phellodendrine and magnoflorine were simultaneously determinated by the HPLC-DAD. Berberine was the primary component in all CP samples, and the contents of berberine and palmatine were exploited to be two critical parameters for effective discrimination between the two species of CP. The average content of berberine in CPC(58.75 mg/g) was higher than that in CPA(9.16 mg/g), while the content of palmatine was less, only 0.25 mg/g in CPC and 4.19 mg/g in CPA. With the use of PCA, samples datasets were separated successfully into two different clusters corresponding to the two species, and berberine, pahnatine, phellodendrine and magnoflorine contribute most to the above mentioned calssifying . The proposed method oroved to be a useful tool in the aualitv control of Chinese herbal medicines.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2011年第1期38-44,共7页 高等学校化学研究(英文版)
基金 Supported by the National Natural Science Foundation of China(No30725045) the Foundation of Eleventh Five-Year-Plan of China(No2008ZX09202-002) the Shanghai Leading Academic Discipline Project, China(NoB906) the Scientific Foundation of Shanghai City, China(No07DZ19702)
关键词 Cortex Phellodendri ALKALOID HPLC-ESI-MS/MS Quantitative analysis Qualitative analysis Principal component analysis Cortex Phellodendri Alkaloid HPLC-ESI-MS/MS Quantitative analysis Qualitative analysis Principal component analysis
  • 相关文献

参考文献28

  • 1Yang M.,Sun J.H.,Lu Z.Q.,Chen G.T.,Guan S.H.,Liu X.,Jiang B.H.,Ye M.,Guo D.A.,J.Chrormatogr.A,2009,1216,2045.
  • 2Yan D.,Jin C.,Xiao X.H.,Dong X.P.,J.Biochem.Biophys.Methods,2008,70,845.
  • 3Liang M.J.,Zhang W.D.,Hua J.,Liu R.H.,Zhang C.,J.Pharm.Biota.Anal.,2006,42,178.
  • 4Zhou H.,Tai Y.P.,Sun C.R.,Pan Y.J.,Phytochem Anal.,2005,16,328.
  • 5Birdsall T.C.,Kelly G.S.,Altern Meal,1997,2,94.
  • 6Anis K.V.,Kuttan G.,Pharm Pharmacol.,1999,5,697.
  • 7Li C.Y.,Lu H.J.,Lin C.H.,Wu T.S.,J.Pharm.Biomed.,2006,40,173.
  • 8Chinese Pharmacopoeia Committee,Pharmacopoeia of the People's Republic of China,Chemical and Industrial Publisher,Beijing,2005,99,214.
  • 9Zhou H.R.,Zhou Y.C.,China Journal of Chinese Materia Medica,1995,20,405.
  • 10QuA.T.,Tan J.,Xiu L.W.,Peng J.W.,Feng B.L.,Zhao C.P.,West China Journal of Pharmaceutical Sciences,2006,21,265.

同被引文献224

引证文献19

二级引证文献242

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部